Servier on the front line of cardiovascular disease prevention and therapeutic adherence
All the news from Servier Group
Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
Patient associations’ perception of pharmaceutical companies: Servier is making progress!
“For a positive and lasting impact”: discover the 2022 CSR publication
Depression: Servier strengthens its collaboration with the patient association GAMIAN-Europe
World Hypertension Day: our commitment in video!
Nicolas Lévy joins Servier as Chief Scientist Rare Diseases
Focus on innovation: Servier sponsors Paris-Saclay SPRING!